Back
CytomX Therapeutics Quote, Financials, Valuation and Earnings
Sell
15
CTMX
CytomX Therapeutics
Last Price:
2.00
Seasonality Move:
-12.9%
7 Day Trial
ALL ACCESS PASS
$
7
CytomX Therapeutics Price Quote
$2.00
+0.04 (+2.04%)
(Updated: May 16, 2024 at 6:55 PM ET)
CytomX Therapeutics Key Stats
Sell
15
CytomX Therapeutics (CTMX)
is a Sell
Day range:
$1.93 - $2.01
52-week range:
$1.04 - $5.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.28
P/B ratio:
0%
Volume:
3.9M
Avg. volume:
12.1M
1-year change:
7.69%
Market cap:
$152.7M
Revenue:
$101.2M
EPS:
$0.2
How Much Does CytomX Therapeutics Make?
-
How Much Are CytomX Therapeutics's Sales Annually?
CTMX Revenues are $101.2M -
How Much Profit Does CytomX Therapeutics's Make A Year?
CTMX net income is -$569K
Is CytomX Therapeutics Growing As A Company?
-
What Is CytomX Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.76% -
What Is CytomX Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
CytomX Therapeutics Stock Price Performance
-
Did CytomX Therapeutics Stock Go Up Last Month?
CytomX Therapeutics share price went down by -0.51% last month -
Did CTMX's Share Price Rise Over The Last Year?
CTMX share price rose by 7.69% over the past 1 year
What Is CytomX Therapeutics 52-Week High & Low?
-
What Is CytomX Therapeutics’s 52-Week High Share Price?
CytomX Therapeutics has traded as high as $5.85 over the past 52 weeks -
What Is CytomX Therapeutics’s 52-Week Low Share Price?
CytomX Therapeutics has traded as low as $1.04 over the past 52 weeks
CytomX Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy CytomX Therapeutics?
-
How Much Debt Does CytomX Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does CytomX Therapeutics Have?
Cash and short term investments quarterly total is $150.3M -
What Is CytomX Therapeutics’s Book Value Per Share?
Book value per share is -0.46
Is CytomX Therapeutics Cash Flow Positive?
-
What Is CTMX Cash Flow From Operations?
Cash flow from operations (TTM) is -$91.4M -
What Is CytomX Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $30.4M -
What Is CytomX Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $40.9M
CytomX Therapeutics Return On Invested Capital
Data Unavailable
CytomX Therapeutics Earnings Date & Stock Price
-
What Is CytomX Therapeutics's Stock Price Today?
A single share of CTMX can be purchased today for 1.96 -
What Is CytomX Therapeutics’s Stock Symbol?
CytomX Therapeutics trades on the nasdaq under the ticker symbol: CTMX -
When Is CytomX Therapeutics’s Next Earnings Date?
The next quarterly earnings date for CytomX Therapeutics is scheduled on August 8, 2024 -
When Is CTMX's next ex-dividend date?
CytomX Therapeutics's next ex-dividend date is May 12, 2020 -
How To Buy CytomX Therapeutics Stock?
You can buy CytomX Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CytomX Therapeutics Competitors
-
Who Are CytomX Therapeutics's Competitors?
Below is a list of companies who compete with CytomX Therapeutics or are related in some way:
CytomX Therapeutics Dividend Yield
Data Unavailable
CytomX Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 382.06% |
| Revenue: | 76.45% | 90.89% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 5.07 |
| Upside from Last Price: | 158.57% |